November 26, 2025

Long-term calorie restriction may slow normal brain aging

November 26, 2025 / Research update / InnovateMed Author / brain aging

by Boston University School of Medicine edited by Gaby Clark, reviewed by Robert Egan Editors’ notes CR synaptic OL subcluster is enriched for essential myelin synthesis pathways. Credit: Aging Cell (2025). DOI: 10.1111/acel.70298 As the brain ages, cells in the central nervous system experience metabolic dysfunction and increased oxidative damage. These cellular issues impair the ability to maintain the myelin […]

Long-term calorie restriction may slow normal brain aging Read More »

Pro fighters risk damage to the brain’s ‘garbage disposal’

November 26, 2025 / Clinical Practice / InnovateMed Author / garbage disposal

by Radiological Society of North America edited by Sadie Harley, reviewed by Robert Egan Editors’ notes The brain’s waste-clearing system significantly declines in function with repeated head impacts, according to a new study of cognitively impaired professional boxers and mixed martial arts fighters. Color display of diffusion tensor imaging indicating the distribution of projection fibers (z-axis: blue), association

Pro fighters risk damage to the brain’s ‘garbage disposal’ Read More »

Is AI making some people delusional? Families and experts are worried

November 26, 2025 / Clinical Practice / InnovateMed Author / delusional

by Nilesh Christopher edited by Sadie Harley, reviewed by Andrew Zinin Editors’ notes Credit: Pixabay/CC0 Public Domain Generative artificial intelligence has quickly permeated much of what we do online, proving helpful for many. But for a small minority of the hundreds of millions of people who use it daily, AI may be too supportive, mental health experts

Is AI making some people delusional? Families and experts are worried Read More »

Why certain arthritis drugs don’t work in rheumatoid arthritis

November 26, 2025 / Clinical Practice / InnovateMed Author / rheumatoid arthritis

by Cedars-Sinai Medical Center edited by Sadie Harley, reviewed by Robert Egan Editors’ notes Credit: Towfiqu barbhuiya from Pexels Cedars-Sinai investigators may have figured out why certain immunosuppressive treatments don’t work well in rheumatoid arthritis. In a study published in Science Immunology, scientists trace the problem to specific changes that occur in immune cells within the joints as the

Why certain arthritis drugs don’t work in rheumatoid arthritis Read More »

Finerenone shows superior survival and kidney protection over spironolactone in diabetic kidney disease

November 26, 2025 / Research update / InnovateMed Author / diabetic kidney disease

by National Taiwan University edited by Sadie Harley, reviewed by Robert Egan Editors’ notes Comparative outcomes of finerenone versus spironolactone in patients with chronic kidney disease (CKD) and type 2 diabetes (T2D). Credit: National Taiwan University Researchers from National Taiwan University Hospital and collaborating institutions have demonstrated that finerenone, a new-generation nonsteroidal mineralocorticoid receptor antagonist (MRA), significantly reduces

Finerenone shows superior survival and kidney protection over spironolactone in diabetic kidney disease Read More »

Should You Add a Ginger Shot to Your Drinks? A Review of the Benefits Before You Decide

November 26, 2025 / Patient education / InnovateMed Author

Key takeaways: Ginger is full of anti-inflammatory compounds that can help with digestion, nausea, and pain relief. Drinking ginger shots might help lower blood sugar and reduce the risk for diabetes. A ginger shot isn’t the only way to get the benefits of ginger, but it gives you the most concentrated, whole-food form. Ginger shots

Should You Add a Ginger Shot to Your Drinks? A Review of the Benefits Before You Decide Read More »

FDA approves Otsuka’s kidney drug, paving the way for novel mechanism

November 26, 2025 / News update / InnovateMed Author / kidney drugs

The FDA yesterday approved a novel drug from Otsuka to treat a chronic, autoimmune kidney disease. The drug, called Voyxact, is part of an emerging class of drugs for IgA nephropathy, or IgAN, a disease caused by the build-up of immune antibodies in the kidneys. The condition, which leads to progressive loss of kidney function, can

FDA approves Otsuka’s kidney drug, paving the way for novel mechanism Read More »

Reducing social media use for just a week can improve mental health

November 26, 2025 / Patient education / InnovateMed Author / mental health

by Krystal Kasal, Medical Xpress edited by Gaby Clark, reviewed by Robert Egan Editors’ notes Credit: Unsplash/CC0 Public Domain In a new study, published in JAMA Network Open, 295 participants report promising mental health benefits after reducing their social media usage for a week. The cohort consisted of young adults from the ages of 18 to 24—the age group commonly associated

Reducing social media use for just a week can improve mental health Read More »

An fMRI marker of Alzheimer’s-related cognitive decline

November 26, 2025 / Clinical Practice / InnovateMed Author / alzheimer

by Justin Jackson, Medical Xpress edited by Sadie Harley, reviewed by Robert Egan Editors’ notes Sagittal and coronal views of the components number 2 and 10 obtained by group ICA, the default mode network (DMN) and dorsal attention network (DAN) respectively. Credit: NeuroImage (2025). DOI: 10.1016/j.neuroimage.2025.121509 Researchers at Université Savoie Mont Blanc, Radboud University and the University of Oxford’s Wellcome

An fMRI marker of Alzheimer’s-related cognitive decline Read More »

Drug Used for Enlarged Prostate Tied to High Glaucoma Risk

November 26, 2025 / Research update / InnovateMed Author / glaucoma

Edited by Archita Rai November 17, 2025 TOPLINE: Men with benign prostatic hyperplasia (BPH) who took alpha-blockers to manage the condition were roughly 50% more likely to develop acute angle-closure glaucoma than were those who did not use the medication, and the incidence increased with longer exposure to the drugs. METHODOLOGY: Researchers investigated whether

Drug Used for Enlarged Prostate Tied to High Glaucoma Risk Read More »